Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Profound Medical Corp.
< Previous
1
2
Next >
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 06, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
December 19, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 07, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces First Quarter 2025 Financial Results
May 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Save the Date: Profound Medical to Host Investor Event at AUA 2025
March 25, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.